ketamine IV anesthetic
Selected indexed studies
- Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. (Neurology, 2022) [PMID:35817569]
- Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. (J Affect Disord, 2024) [PMID:38537759]
- Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial. (JAMA Psychiatry, 2025) [PMID:40601310]
_Worker-drafted node — pending editorial review._
Connections
ketamine IV anesthetic is a side effect of
Sources
- Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. (2024) pubmed
- Ketamine and Esketamine in Clinical Trials: FDA-Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations. (2025) pubmed
- Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study. (2021) pubmed
- Intravenous (IV) ketamine versus intranasal esketamine for depression- Advantage IV ketamine? (2024) pubmed
- Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial. (2025) pubmed
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. (2018) pubmed
- Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. (2022) pubmed
- Intranasal ketamine for anesthetic premedication in children: a systematic review. (2018) pubmed
- Ketamine as an Anesthetic for Patients with Acute Brain Injury: A Systematic Review. (2020) pubmed
- Personalizing ketamine therapy: Real-world predictors of response to IV ketamine and intranasal esketamine in treatment-resistant depression. (2025) pubmed